Dr. Emily Whitman
Claim this profileZangmeister Cancer Center
Studies Ovarian Cancer
Studies Ovarian Tumors
2 reported clinical trials
4 drugs studied
Area of expertise
1Ovarian Cancer
FRα positive
BRCA positive
2Ovarian Tumors
FRα positive
BRCA positive
Affiliated Hospitals
More about Emily Whitman
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Emily Whitman has experience with
- Mirvetuximab Soravtansine
- Paclitaxel
- Pegylated Liposomal Doxorubicin
- Topotecan
Breakdown of trials Emily Whitman has run
Fallopian Tube Cancer
Peritoneal Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Whitman specialize in?
Emily Whitman focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved FRα positive patients, or patients who are BRCA positive.
Is Emily Whitman currently recruiting for clinical trials?
No, Emily Whitman is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Emily Whitman has studied deeply?
Yes, Emily Whitman has studied treatments such as Mirvetuximab Soravtansine, Paclitaxel, Pegylated liposomal doxorubicin.
What is the best way to schedule an appointment with Emily Whitman?
Apply for one of the trials that Emily Whitman is conducting.
What is the office address of Emily Whitman?
The office of Emily Whitman is located at: Zangmeister Cancer Center, Columbus, Ohio 43219 United States. This is the address for their practice at the Zangmeister Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.